Skip to content

Women's Oral /Periodontal Status and Related Mother-Infant Health: Metagenomics- and Ramanomics-based Assessment of Microbiome & Clinical Applications

Women's Oral/Periodontal Status and Related Mother-Infant Health: Metagenomics- and Ramanomics-based Assessment of Microbiome & Clinical Applications

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000034738
Enrollment
Unknown
Registered
2020-07-17
Start date
2020-07-20
Completion date
Unknown
Last updated
2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontal disease

Interventions

Women with various periodontal status:Nil

Sponsors

Shenzhen Maternity and Child Healthcare Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1. Vertical scheme: (1) Those who do not smoke or drink alcohol; (2) Subjects with normal dietary habits (non vegetarians or dieters to lose weight); (3) Subjects with normal BMI; (4) Those who did not receive periodontal treatment within 12 months; (5) Subjects without systemic diseases except oral and obstetric conditions (see exclusion criteria); (6) Those who did not use antibiotics in the last three months at least; (7) Objects with at least 20 teeth (excluding the third molar). 2. Horizontal plan: According to the pre pregnancy history and related clinical examination results, according to the inclusion criteria of the longitudinal program.

Exclusion criteria

Exclusion criteria: 1. Vertical scheme: (1) Systemic diseases such as diabetes, cardiovascular diseases, cancer, infectious diseases, such as AIDS, hepatitis B, syphilis, etc.; (2) Patients who continue to take immunosuppressants, bisphosphonates, steroids and other hormones and immune related drugs; They had a history of repeated premature delivery, previous adverse pregnancy, need for assisted reproduction (multiple pregnancy), and immune system diseases; (3) After that, gynecological examination, gynecologic ultrasound, sex hormone test (menstrual day 2-4), eugenics, vaginal microecological examination, Mycoplasma Chlamydia test, cervical examination (LCT, HPV typing), blood routine, urine routine, blood glucose, glycosylated hemoglobin, blood pressure, blood lipid, thyroid hormone test, liver and kidney function, infectious disease examination (hepatitis B, syphilis, AIDS, hepatitis C, etc.) The results of relevant examination were abnormal; (4) Subjects will also be asked not to take probiotics or probiotics; (5) Subjects who did not successfully conceive within one year. 2. Horizontal plan: According to the pre pregnancy history and related clinical examination results, according to the exclusion criteria of longitudinal program.

Design outcomes

Primary

MeasureTime frame
Microbiomes;oral/periodontal parameters;alveolar bone condition;

Secondary

MeasureTime frame
Mothers' general condition;Newborns' general condition;Biomarkers;

Countries

China

Contacts

Public ContactJin Lijian, Yao Jilong

Department of Dentistry, University of Hong Kong; Shenzhen maternal and child health hospital

ljjin@hku.hk+86 852-28590302, +86 13823556088

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026